Aspirin Twice Daily in Diabetic Patients With Coronary Artery Disease
NCT01617031 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92
Last updated 2012-06-12
Summary
The aim of the study is to evaluate platelet function variations according to the delay since last aspirin intake (12 vs 24 hours)in a population of diabetic patients with previous Coronary Artery Disease.
Conditions
Sponsors & Collaborators
-
Hopital Lariboisière
lead OTHER
Principal Investigators
-
Patrick Henry, MD-PhD · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2011-03-31
- Completion
- 2012-05-31
Countries
- France
Study Locations
More Related Trials
-
Comparison of Effects of Buffered and Enteric-coated Forms of Aspirin on Platelet Aggregation in Patients With Diabetes Mellitus and Chronic Coronary Syndrome
NCT06716255 ·Status: COMPLETED
-
Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease
NCT02370680 ·Status: COMPLETED ·Phase: PHASE1
-
Laboratory Aspirin Resistance in Diabetics and Non-Diabetics
NCT00563875 ·Status: COMPLETED ·Phase: NA
-
Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients
NCT00129038 ·Status: COMPLETED ·Phase: PHASE4
-
Chronotherapy with Low-dose Aspirin for Primary Prevention
NCT00725127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Duration of Platelet Inhibition by Aspirin
NCT00671021 ·Status: COMPLETED
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
NCT05702463 ·Status: RECRUITING ·Phase: PHASE1
-
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
NCT00966485 ·Status: COMPLETED ·Phase: NA
-
Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
NCT00793754 ·Status: COMPLETED ·Phase: PHASE4
-
DS1040b/Aspirin Drug/Drug Interaction Study
NCT02071004 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Response in High Risk Patients With Coronary Artery Disease
NCT01383304 ·Status: UNKNOWN
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes
NCT05105919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Subclinical Inflammation and High Cardiovascular Risk
NCT02164578 ·Status: COMPLETED ·Phase: PHASE3
-
WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?
NCT04990791 ·Status: COMPLETED ·Phase: PHASE4
-
Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
NCT05304845 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes
NCT02895113 ·Status: UNKNOWN ·Phase: PHASE3
-
Aspirin Responsiveness in Women With Coronary Artery Disease
NCT01406990 ·Status: COMPLETED
-
Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
NCT04484259 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
NCT00272311 ·Status: COMPLETED ·Phase: PHASE4
-
Japanese Primary Prevention Project With Aspirin
NCT00225849 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy
NCT01852162 ·Status: COMPLETED ·Phase: NA
-
To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects
NCT01424332 ·Status: COMPLETED ·Phase: PHASE1
-
Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)
NCT01212302 ·Status: COMPLETED ·Phase: NA
-
Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
NCT00110448 ·Status: COMPLETED ·Phase: PHASE4